These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 36326540)
1. Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation. Jin N; Chen R; Li Y; Zhang Z; Zhang B; Chen J Eur J Pharm Sci; 2023 Jan; 180():106314. PubMed ID: 36326540 [TBL] [Abstract][Full Text] [Related]
2. Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid. Jin N; Lin J; Yang C; Wu C; He J; Chen Z; Yang Q; Chen J; Zheng G; Lv L; Liang H; Chen J; Ruan Z Int J Pharm; 2020 Mar; 578():119101. PubMed ID: 32006622 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizic acid assists anti-psoriatic efficacy of a self-deformable curcumin loaded transdermal gel. Jin N; He J; Wu C; Chen Z; Li Y; Chen J; Lin J Pharm Dev Technol; 2022 Mar; 27(3):282-289. PubMed ID: 35152822 [TBL] [Abstract][Full Text] [Related]
4. TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. Guo T; Lu J; Fan Y; Zhang Y; Yin S; Sha X; Feng N Int J Pharm; 2021 Jul; 604():120762. PubMed ID: 34082000 [TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Kang NW; Kim MH; Sohn SY; Kim KT; Park JH; Lee SY; Lee JY; Kim DD Biomaterials; 2018 Nov; 182():245-258. PubMed ID: 30142524 [TBL] [Abstract][Full Text] [Related]
6. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of curcumin-loaded glycyrrhizic acid nanoparticles for anti-inflammatory therapy. Piao C; Zhuang C; Kang M; Oh J; Lee M Biomater Sci; 2022 Nov; 10(23):6698-6706. PubMed ID: 36263591 [TBL] [Abstract][Full Text] [Related]
8. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model. Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818 [TBL] [Abstract][Full Text] [Related]
9. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. Iriventi P; Gupta NV; Osmani RAM; Balamuralidhara V Daru; 2020 Dec; 28(2):489-506. PubMed ID: 32472531 [TBL] [Abstract][Full Text] [Related]
10. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829 [TBL] [Abstract][Full Text] [Related]
11. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282 [TBL] [Abstract][Full Text] [Related]
12. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin. Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553 [No Abstract] [Full Text] [Related]
13. Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects. Mousa AM; Alhumaydhi FA; Abdellatif AAH; Abdulmonem WA; AlKhowailed MS; Alsagaby SA; Al Rugaie O; Alnuqaydan AM; Aljohani ASM; Aljasir M; Alwashmi ASS; Soliman KEA; Yosof MYR; Elsheikh SY; Babiker AY; Alsuhaibani SA; Hegazy AMS; Seleem HS Cutan Ocul Toxicol; 2022 Mar; 41(1):33-42. PubMed ID: 34749565 [TBL] [Abstract][Full Text] [Related]
14. Formulation of Glycyrrhizic Acid-based Nanocomplexes for Enhanced Anti-cancer and Anti-inflammatory Effects of Curcumin. Song J; Kim JY; You G; Kang YY; Yang J; Mok H Biotechnol Bioprocess Eng; 2022; 27(2):163-170. PubMed ID: 35530367 [TBL] [Abstract][Full Text] [Related]
15. Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery. Malekmohammadi S; Hadadzadeh H; Farrokhpour H; Amirghofran Z Soft Matter; 2018 Mar; 14(12):2400-2410. PubMed ID: 29512668 [TBL] [Abstract][Full Text] [Related]
16. Synergistic Effects of Photo-Irradiation and Curcumin-Chitosan/Alginate Nanoparticles on Tumor Necrosis Factor-Alpha-Induced Psoriasis-Like Proliferation of Keratinocytes. Gomez C; Muangnoi C; Sorasitthiyanukarn FN; Wongpiyabovorn J; Rojsitthisak P; Rojsitthisak P Molecules; 2019 Apr; 24(7):. PubMed ID: 30970577 [TBL] [Abstract][Full Text] [Related]
17. Co-Delivery of Imiquimod and Curcumin by Nanoemugel for Improved Topical Delivery and Reduced Psoriasis-Like Skin Lesions. Algahtani MS; Ahmad MZ; Nourein IH; Ahmad J Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605030 [TBL] [Abstract][Full Text] [Related]
18. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. Jain A; Doppalapudi S; Domb AJ; Khan W J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194 [TBL] [Abstract][Full Text] [Related]
19. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice. Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482 [TBL] [Abstract][Full Text] [Related]
20. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. Lv Y; Li J; Chen H; Bai Y; Zhang L Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]